Blood Advances (ISSN 2473-9529, 2473-9537) is an open-access journal published by American Society of Hematology in the United States. It covers Medicine and Hematology. It is indexed in Scopus, Web of Science, PubMed, DOAJ and HEC. Recorded metrics: impact factor 7.7, Scopus Q1, Web of Science Q1, CiteScore 11.8 and HEC W-Category. Article processing charge: USD 4,000. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, waiver policy, time to publication, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.
Blood Advances
Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.
Journal lists: Q1 journals · HEC W category journals · Scopus journals · Web of Science journals · PubMed journals · DOAJ journals · SCImago journals · SCIE journals · Impact factor journals · Open access journals · Scopus Q1 journals · Web of Science Q1 journals · Open access Q1 journals · Q1 Medicine journals · Q1 Hematology journals
Quick answers about Blood Advances
Is Blood Advances HEC recognised?
Yes. The catalogue records Blood Advances in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Blood Advances indexed in Scopus?
Yes. Blood Advances is listed as Scopus-indexed, in quartile Q1, with a CiteScore of 11.8. Check its current status on the Scopus Sources page.
Is Blood Advances in Web of Science?
Yes. Blood Advances is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q1. Confirm on Clarivate's Master Journal List.
What is the impact factor of Blood Advances?
The recorded journal impact factor of Blood Advances is 7.7. Clarivate updates impact factors every year in Journal Citation Reports.
Is Blood Advances open access, and what does it charge?
Blood Advances is an open-access journal and its APC is USD 4,000. Fees change, so check the journal's website before you submit.
How long does Blood Advances take to publish?
The recorded average time from submission to publication is about 16 weeks. Individual papers can take longer, especially when revisions are requested.
Who publishes Blood Advances?
Blood Advances is published by American Society of Hematology in United States, under ISSN 2473-9529 and 2473-9537.
Research profile
- 6,402articles indexed
- 181,102citations
- 141h-index
- 6.522-year mean citedness
- 1920first year indexed
Main research topics: Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Chronic Lymphocytic Leukemia Research, Platelet Disorders and Treatments, Acute Lymphoblastic Leukemia research.
Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.
Browse similar journals
- Medicine journals (8,023)
- Hematology journals (159)
- Journals indexed in Scopus (31,185)
- Journals indexed in Web of Science (22,643)
- Journals indexed in PubMed (16,086)
- Journals indexed in DOAJ (10,243)
- Journals indexed in HEC (34,823)
- Scopus Q1 journals (9,924)
- Web of Science Q1 journals (4,519)
- HEC W-Category journals (13,616)
- Journals published in the United States (7,575)